发明名称 |
EGLN2 VARIANTS AND USE THEREOF IN PREVENTING OR TREATING THROMBOEMBOLIC DISORDERS AND CORONARY HEART DISEASES |
摘要 |
The present invention refers to human EGLN2 variants having at position 58 of the amino acid sequence a serine or a leucine and their use in the prevention or treatment of thromboembolic or coronary heart diseases, in particular stroke, prolonged reversible ischemic neurological deficit (PRIND), transitoric ischemic attack (TIA), myocardial infarction and/or early myocardial infarction. |
申请公布号 |
US2012096571(A1) |
申请公布日期 |
2012.04.19 |
申请号 |
US201113331581 |
申请日期 |
2011.12.20 |
申请人 |
KOZIAN DETLEF;HERRMANN MATTHIAS;SANOFI |
发明人 |
KOZIAN DETLEF;HERRMANN MATTHIAS |
分类号 |
C12P21/02;A01K67/027;C12N1/19;C12N1/21;C12N5/10;C12N15/12;C12N15/63 |
主分类号 |
C12P21/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|